Ra Pharmaceuticals Inc (RARX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

87 CAMBRIDGE PARK DRIVE CAMBRIDGE, MA 02140

Ra Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company offers drugs for the treatment of cancer, inflammation and autoimmune disease, diabetes, and cardiovascular. Ra Pharmaceuticals conducts its business in the United States.

Data based on most recent fiscal year report
Market Cap120.165 Million Shares Outstanding22.63 Million Avg Volume262.466 Thousand
1-Yr BETA vs S&P TR1.218 Current Ratio8.46 Quick Ratio8.46
View SEC Filings from RARX instead.
Q3 2019 All Institutions Hedge Funds 1
To trade RARX now:
Filers who had this stock in their top 10: 5 1 (0.1%)
13F Filers holding this stock: 117 23 (2.4%)
Aggregate 13F shares on 09/30/2019: 47.224 Million 15.99 Million
Aggregate 13F shares on 06/30/2019: 43.058 Million 14.114 Million
Percent change: 9.67% 13.30%
Funds creating new positions: 17 6
Funds Adding to an existing position: 59 11
Funds closing out their position: 16 5
Funds reducing their position: 25 5
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RARX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

22.9 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

20.6 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOVO HOLDINGS A/S

  • 10% Owner
  • SEE REMARKS
3,409,021 2019-11-12 0

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • 10% Owner
3,543,067 2019-11-12 0

KERINS PATRICK J

  • 10% Owner
5,925,287 2019-10-30 0

BARRIS PETER J

  • 10% Owner
322,458 2019-10-30 0

RICARDO ALONSO SEE REMARKS

  • Officer
6,858 2019-10-17 4

READ SIMON CHIEF SCIENTIFIC OFFICER

  • Officer
6,234 2019-10-16 6

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • 10% Owner
5,422,312 2019-10-16 0

FARZANEH-FAR RAMIN CHIEF MEDICAL OFFICER

  • Officer
7,132 2019-10-15 6

MOTT DAVID M

  • Director
4,443,435 2019-09-30 0

BRENNAN AOIFE SEE REMARKS

  • Officer
  • Director
59,767 2019-09-23 1

SHAH RAJEEV M.

  • Director
  • 10% Owner
4,681,858 2019-09-17 2

SANDELL SCOTT D

  • Director
  • 10% Owner
4,059,376 2019-09-17 0

BASKETT FOREST

  • 10% Owner
4,186,243 2019-07-22 0

MATHERS EDWARD T

  • Director
0 2019-07-17 1

HEFT ROBERT

  • Director
0 2019-06-11 1

PEARSON TIMOTHY R

  • Director
0 2019-06-11 1

CUMBO ALEXANDER

  • Director
0 2019-06-11 1

LUBNER DAVID CHARLES

  • Director
0 2019-06-07 1

BARRETT M JAMES

  • Director
0 2019-05-30 0

KING JOHN C CHIEF COMMERCIAL OFFICER

  • Officer
10,823 2019-04-16 2

TRECO DOUGLAS A PRESIDENT AND CEO

  • Officer
  • Director
218,799 2019-02-01 1

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • Director
  • 10% Owner
7,775,207 2019-01-24 2

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
0 2019-01-22 1

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

MOTT DAVID M

SANDELL SCOTT D

  • 10% Owner
6,135,234 2018-12-14 1

MORGENTHALER VENTURE PARTNERS IX LP

MORGENTHALER MANAGEMENT PARTNERS IX, LLC

  • 10% Owner
No longer subject to file 2018-11-16 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

BARRETT M JAMES

BARRIS PETER J

BASKETT FOREST

KERINS PATRICK J

MOTT DAVID M

SANDELL SCOTT D

VISWANATHAN RAVI

  • 10% Owner
6,641,634 2018-10-22 1

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

BISGAARD PETER

  • Director
0 2018-06-28 0

LETTMANN JASON

  • Director
  • 10% Owner
0 2017-06-20 0

KOLLURI KRISHNA KITTU

  • 10% Owner
5,215,128 2016-12-19 0

WELLER HARRY R

  • 10% Owner
3,490,073 2016-10-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RICARDO ALONSO - Officer SEE REMARKS

2019-10-17 S 2,285 $46.70 d 6,858 6,858.00 direct yes

READ SIMON - Officer CHIEF SCIENTIFIC OFFICER

2019-10-16 M 10,000 $2.87 a 16,234 6,234.00 direct

READ SIMON - Officer CHIEF SCIENTIFIC OFFICER

2019-10-16 M 10,000 d 66,142 6,234.00 direct

READ SIMON - Officer CHIEF SCIENTIFIC OFFICER

2019-10-16 S 10,000 $46.87 d 6,234 6,234.00 direct yes

FARZANEH-FAR RAMIN - Officer CHIEF MEDICAL OFFICER

2019-10-15 S 10,595 $46.89 d 7,132 7,132.00 direct yes

FARZANEH-FAR RAMIN - Officer CHIEF MEDICAL OFFICER

2019-10-15 M 9,206 d 119,684 7,132.00 direct

FARZANEH-FAR RAMIN - Officer CHIEF MEDICAL OFFICER

2019-10-15 M 9,206 $5.60 a 17,727 7,132.00 direct

FARZANEH-FAR RAMIN - Officer CHIEF MEDICAL OFFICER

2019-10-15 M 1,389 d 18,055 7,132.00 direct

FARZANEH-FAR RAMIN - Officer CHIEF MEDICAL OFFICER

2019-10-15 M 1,389 $5.60 a 8,521 7,132.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments